Product Information
RITALIN 10 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $1.1332 per EA under NDC 00078044005. Its NADAC has been published 649 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078044005
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA010187FDA Approved
Before 1982
TE Code
AB
On Market Since
12/31/1955
Pharmacological Classes
Price Statistics
The NADAC for RITALIN 10 MG TABLET has been published 649 times since Nov 28, 2013, and over the history we have for it it has risen 23.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1332 per EA |
|---|---|
| All-time high | $1.1448 (Jul 10, 2024) |
| All-time low | $0.8900 (Nov 22, 2017) |
| 52-week high | $1.1332 |
| 52-week low | $1.1317 |
| Median price | $0.9022 |
| Average price | $0.9588 |
| Largest weekly change | +9.9% (Mar 20, 2024) |
| Weeks tracked | 649 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
0.0%
3M
+0.0%
6M
+0.1%
1Y
+0.1%
3Y
+9.5%
5Y
+25.6%
All
+23.3%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RITALIN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RITALIN 10 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $1.1332 per EA (NDC 00078044005), effective Jul 29, 2026.
How has the price of RITALIN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for RITALIN 10 MG TABLET has risen 23.3%. It has been tracked across 649 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RITALIN 10 MG TABLET?
Since Nov 28, 2013, the NADAC for RITALIN 10 MG TABLET has ranged from a low of $0.8900 (Nov 22, 2017) to a high of $1.1448 (Jul 10, 2024), with a median of $0.9022 per EA.
Are there cheaper alternatives to RITALIN 10 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RITALIN 10 MG TABLET, is $1.1327 per EA — about 0% below RITALIN 10 MG TABLET.
Who manufactures RITALIN 10 MG TABLET?
RITALIN 10 MG TABLET (NDC 00078044005) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.